Discover recent press, blog posts and announcements from Sequoia.

News

Sequoia Reinsurance Services offers a portfolio of reinsurance solutions to support companies as they work to manage medical risk and contain costs.

BioMarin Delays Planned FDA Filing

BioMarin Delays Planned FDA Filing

Click here to download PDF

READ MORE
Medicaid Best Price 101

Medicaid Best Price 101

Click here to download PDF

READ MORE
Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma (LBCL)

Yescarta® Receives U.S. FDA Approval as First CAR T-cell…

Click here to download PDF

READ MORE
Sequoia – Cell & Gene Therapy Risk Solutions

Sequoia – Cell & Gene Therapy Risk Solutions

Click here to download PDF

READ MORE
Sequoia Branch Bill Review Extended ICU LOS

Sequoia Branch Bill Review Extended ICU LOS

Sequoia Branch Bill Review Extended ICU LOS

READ MORE
Phase 3 Trial of Hemophilia A Gene Therapy SB-525

Phase 3 Trial of Hemophilia A Gene Therapy SB-525

Phase 3 Trial of Hemophilia A Gene Therapy SB-525

READ MORE
Sequoia Branch Oncology Claims Negotiation

Sequoia Branch Oncology Claims Negotiation

Sequoia Branch Oncology Claims Negotiation

READ MORE
Novartis’ Kymriah fails to meet primary goal in non-Hodgkin lymphoma trial

Novartis’ Kymriah fails to meet primary goal in non-Hodgkin…

Novartis’ Kymriah fails to meet primary goal in non-Hodgkin lymphoma trial

READ MORE
New data show BioMarin’s troubled hemophilia gene therapy continues to fade, opening room for rivals – Endpoints News

New data show BioMarin’s troubled hemophilia gene therapy continues…

New data show BioMarin’s troubled hemophilia gene therapy continues to fade, opening room for rivals – Endpoints News

READ MORE
Bluebird cleared by FDA to resume studies of sickle cell gene therapy – BioPharma Dive

Bluebird cleared by FDA to resume studies of sickle…

Bluebird cleared by FDA to resume studies of sickle cell gene therapy

READ MORE
FDA approval sets stage for a showdown between Alexion and Apellis BioPharma Dive

FDA approval sets stage for a showdown between Alexion…

FDA approval sets stage for a showdown between Alexion and Apellis BioPharma Dive

READ MORE
FDA approves ADC Therapeutics antibody drug conjugate in B-cell lymphoma – MedCity News

FDA approves ADC Therapeutics antibody drug conjugate in B-cell…

FDA approves ADC Therapeutics antibody drug conjugate in B-cell lymphoma - MedCity News

READ MORE
U.S. Food and Drug Administration Approves Bristol Myers Squibbs and bluebird bios Abecma (idecabtagene vicleucel) the First Anti-BCMA CAR T Cell Therapy for Relapse

U.S. Food and Drug Administration Approves Bristol Myers Squibbs…

U.S. Food and Drug Administration Approves Bristol Myers Squibbs and bluebird bios Abecma (idecabtagene vicleucel)

READ MORE
Gilead’s Kite keeps adding to CAR-T Yescarta’s bag of tricks with FDA approval in follicular lymphoma — a first – Endpoints News

Gilead’s Kite keeps adding to CAR-T Yescarta’s bag of…

Gilead’s Kite keeps adding to CAR-T Yescarta’s bag of tricks

READ MORE
Bristol Myers finally wins FDA approval for cancer cell therapy _ BioPharma Dive

Bristol Myers finally wins FDA approval for cancer cell…

Bristol Myers finally wins FDA approval for cancer cell therapy

READ MORE
CMS Issues Final Rule to Empower States, Manufacturers, and Private Payers to Create New Payment Methods for Innovative New Therapies Based on Patient Outcomes _ CMS

CMS Issues Final Rule to Empower States, Manufacturers, and…

CMS Issues Final Rule to Empower States, Manufacturers, and Private Payers

READ MORE
Sequoia Branch Industry Leading Client Savings 2020

Sequoia Branch Industry Leading Client Savings 2020

Sequoia Branch Industry Leading Client Savings 2020

READ MORE
Sequoia Reinsurance Services LLC Announces Agreement with Everest Reinsurance Company

Sequoia Reinsurance Services LLC Announces Agreement with Everest Reinsurance…

Click here to download PDF.

READ MORE
Sequoia Branch CAR T-Cell Insights

Sequoia Branch CAR T-Cell Insights

Click here to download PDF.

READ MORE
Sequoia Underwriting Administrator Announcement

Sequoia Underwriting Administrator Announcement

Click here to download PDF.

READ MORE
COVID-19 Case Branch Savings

COVID-19 Case Branch Savings

COVID-19 Case Branch Savings

READ MORE
NICU Case Branch Savings

NICU Case Branch Savings

NICU Case Branch Savings

READ MORE
COVID Patients Testing Positive

COVID Patients Testing Positive

COVID Patients Testing Positive

READ MORE
Sequoia Presents: The Impact of COVID-19 – Focused Claims Review with Optum

Sequoia Presents: The Impact of COVID-19 – Focused Claims…

Sequoia Presents: The Impact of COVID-19 - Focused Claims Review with Optum

READ MORE
How Much More Than Medicare

How Much More Than Medicare

How Much More Than Medicare

READ MORE
Potential Costs of Coronavirus Treatment

Potential Costs of Coronavirus Treatment

Potential Costs of Coronavirus Treatment

READ MORE
Mass. Outlines Deal For A $2 Million Drug: Pay Only If It Works

Mass. Outlines Deal For A $2 Million Drug: Pay…

Mass. Outlines Deal For A $2 Million Drug: Pay Only If It Works

READ MORE
Reinsurance Market Risk Drivers and Pipeline 2020

Reinsurance Market Risk Drivers and Pipeline 2020

Provided Content is password protected. Click Read More!

READ MORE
Branch Claim Payment Integrity Review

Branch Claim Payment Integrity Review

Branch Claim Payment Integrity Review

READ MORE
Accessibility and Affordability of Gene Therapy

Accessibility and Affordability of Gene Therapy

Accessibility and Affordability of Gene Therapy

READ MORE
Doctor offers unique perspective as father of a child with rare genetic disease

Doctor offers unique perspective as father of a child…

Doctor offers unique perspective as father of a child with rare genetic disease

READ MORE
Market Insight Specialty Pharmacy

Market Insight Specialty Pharmacy

Market Insight Specialty Pharmacy

READ MORE
Market Insight Gene and Immuno – Therapy

Market Insight Gene and Immuno – Therapy

Market Insight Gene and Immuno - Therapy

READ MORE
Long Term Acute Care (LTAC) Hospitals

Long Term Acute Care (LTAC) Hospitals

Long Term Acute Care (LTAC) Hospitals

READ MORE
Market Insight-Hemophilia

Market Insight-Hemophilia

Market Insight-Hemophilia

READ MORE
Market Insight ICER Pharmacy Rebates

Market Insight ICER Pharmacy Rebates

Market Insight ICER Pharmacy Rebates

READ MORE
Sequoia Reinsurance Launches, Focused on HMO Reinsurance and Provider Excess; Backed by ELMC Risk Solutions

Sequoia Reinsurance Launches, Focused on HMO Reinsurance and Provider…

MINNEAPOLIS, June 14, 2018 /PRNewswire/ — Sequoia Reinsurance LLC (“Sequoia”) announced today that it has launched operations focused on HMO reinsurance and provider…

READ MORE
New Reinsurance Firm to Offer Some Employer Stop-Loss

New Reinsurance Firm to Offer Some Employer Stop-Loss

A new, Minneapolis-based health reinsurance firm says it will offer specialized employer stop-loss arrangements, without defining exactly what those arrangements…

READ MORE
Something Happened to U.S. Drug Costs in the 1990s

Something Happened to U.S. Drug Costs in the 1990s

Two decades ago, the costs began rising well beyond that of other nations, and in recent years have shot up…

READ MORE
Branch Program Claim Payment Integrity Review

Branch Program Claim Payment Integrity Review

Branch Program Claim Payment Integrity Review

READ MORE